Comparative results of isolated profundoplasty and distal bypass surgery in patients with diabetes mellitus and trophic ulcers

Aim. To compare the results of lower limb revascularization in patients with diffuse lesions of lower limb arteries who underwent femoral-distal bypass surgery and isolated reconstruction of the deep femoral artery (DFA) in the immediate postoperative period.

Materials and methods. The study included 86 patients with diffuse arterial lesions of lower extremities, 52 (60.4%) men and 34 (39.6%) women with the average age of 67.3 ± 16.8 years. All patients had diffuse lesions of the arteries below the Poupart’s ligament; the condition of the lower leg arteries was 5–8.5 points on the Rutherford scale. Trophic ulcers were present in all cases. Group 1 included 48 patients who underwent reconstruction of lower leg arteries. Group 2 included 38 patients whose surgical intervention was limited to endarterectomy from the common femoral and deep femoral arteries.

Results. In the early postoperative period, 1 (2.1%) patient (from group 1) died from developed myocardial infarction. The patient underwent a femoral-popliteal-tibial bypass surgery with a composite Y-shaped graft. In group 2, no fatal complications were observed. After the operation, all patients demonstrated an increase in the linear blood flow velocity in the arteries of the foot and the transcutaneous oxygen tension (TOT). The TOT level 14 days after surgery comprised 44.1 mm Hg and 39.9 mm Hg (p> 0.05) in groups 1 and 2, respectively.

Conclusions. In 86.8% of patients, isolated profundoplasty followed by vasotropic therapy allows the target values of TOT to be obtained, which is necessary for successful healing of lower limb trophic ulcers.

1. Armstrong E.J., Waltenberger J., Rogers J.H. Percutaneous coronaryintervention in patients with diabetes: current concepts and futuredirections. J. Diabetes Sci. Technol. 2014; 8(3): 581–589. DOI: 10.1177/1932296813517058

2. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998; 339(4): 229–234. DOI: 10.1056/NEJM199807233390404

3. Dick F., Diehm N., Galimanis A., Husmann M., Schmidli J., Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J. Vasc. Surg. 2007; 45(4): 75–761. DOI: 10.1016/j.jvs.2006.12.022

4. Awad S., Karkos C.D., Serrachino-Inglott F., Cooper N.J., Butterfield J.S., Ashleigh R., Nasim A. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. Eur. J. Vasc. Endovasc. Surg.2006; 32(1): 51–59. DOI: 10.1016/j.ejvs.2005.12.019

5. Gavrilenko A.B., Skrylev S.I. Surgical treatment of patients with critical ischemia of the lower extremities with lesions of the arteries of the femoral-popliteal-tibial segment. Khirurgiya. Zhurnal im. N.I. Pirogova. 2004; 8: 36–42 (In Russ.).

6. Aslanov A.D. Tactics of treatment of patients with diffuse lesions of the arteries of the lower extremities: Extended abstract of Doct. Med. Sci. dissertation: 14.00.44. Moscow, 1999. 21 р. (In Russ.).

7. Brochado Neto F.C., Cury M.V., Costa V.S., Casella I.B., Matielo M.F., Nakamura E.T., et al. Inframalleolar bypass grafts for limb salvage. Eur. J. Vasc. Endovasc. Surg. 2010; 40(6): 747–753. DOI: 10.1016/j.ejvs.2010.08.008

8. Feinglass J., Pearce W.H., Martin G.J., Gibbs J., Cowper D., Sorensen M., et al. Postoperative and amputation- free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J. Vasc. Surg. 2001; 34(2): 283–290. DOI: 10.1067/mva.2001.116807

9. Slim H., Tiwari A., Ahmed A., Ritter J.C., Zayed H., Rashid H. Distal versus ultradistal bypass grafts: amputation- free survival and patency rates in patients with critical leg ischaemia. Eur. J. Vasc. Endovasc. Surg. 2011; 42(1): 83–88. DOI: 10.1016/j.ejvs.2011.03.016

10. Rashid H., Slim H., Zayed H., Huang D.Y., Wilkins C.J., Evans D.R., et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J. Vasc. Surg. 2013; 57(5): 1219–1226. DOI: 10.1016/j.jvs.2012.10.129

11. Dorweiler B., Friess T., Duenschede F., Doemland M., Espinola-Klein C., Vahl C.F. Value of the deep femoral artery as alternative inflow source in infrainguinal bypass surgery. Ann. Vasc. Surg. 2014; 28(3): 6 33–639. DOI: 10.1016/j.avsg.2013.04.026

12. Witz M., Shnacker A., Lehmann J.M. Isolated profundoplasty using endarcterectomised superfacial femoral artery for limb salvage in elderly. Minerva Cardioangiol. 2000; 48(12): 451–454.

13. Miksic K., Novak B. Profundafemoris revascularization in limb salvage. J. Cardiovasc. Surg. (Torino). 1986; 27(5): 544–552.

14. Taurino M., Persiani F., Ficarelli R., Filippi F., Dito R., Rizzo L. The role of the profundoplasty in the modern management of patient with peripheral vascular disease. Ann. Vasc. Surg. 2017; 45: 16–21. DOI: 10.1016/j.avsg.2017.05.0182017

15. lgor R.D., Ricotta J.J. 2nd, Bower T.C., Oderich G.S., Kalra M., Duncan A.A., Gloviczki P. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization. Ann. Vasc. Surg. 2012; 26(7): 946–956. DOI: 10.1016/j.avsg.2012.02.014